Clinical Trials

660 enrolled

Phase 2/3 Active not recruiting

Multiple Myeloma

NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT07428369 2026-02-23

LINKER-MM8

Phase 2/3 Not yet recruiting

1,570 enrolled

Multiple Myeloma

NCT05991388 2026-02-20

Glo-BNHL

210 enrolled

Lymphoid

Lymphoma, B-Cell

NCT06616584 2026-01-23

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

378 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07213375 2026-01-07

DEXTER

Phase 2/3 Not yet recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07072585 2025-12-31

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

1,708 enrolled

Phase 2/3 Active not recruiting

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03117751 2025-12-05

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

790 enrolled

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04442022 2025-10-03

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

501 enrolled

Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06855810 2025-08-26

CCCG-TALL-2025

610 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06882057 2025-08-26

CCCG-LR-B-ALL

3,000 enrolled

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Phase 2/3 Active not recruiting

130 enrolled 8 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT05096663 2025-05-15

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

82 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04513639 2025-03-20

The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study

176 enrolled

Multiple Myeloma

NCT06879379 2025-03-17

KPD Consolidation After ASCT in NDMM Patients

202 enrolled

Multiple Myeloma

NCT06764238 2025-02-07

CCCG-I/HR-ALL

1,800 enrolled

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01228331 2024-12-11

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

745 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02416388 2024-08-07

BIG-1

Other hematologic neoplasm

3,100 enrolled

Leukemia, Myeloid, Acute

NCT04061512 2024-05-10

RAINBOW

Other hematologic neoplasm

148 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

NCT00630565 2024-01-29

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Phase 2/3 Terminated

12 enrolled 12 charts

Congenital Abnormalities, Leukemia

NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

20 enrolled

Multiple Myeloma

NCT00199108 2022-08-18

Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03668639 2021-12-14

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

80 enrolled

Gynecologic

Uterine Cervical Neoplasms, Vomiting

NCT00720109 2020-04-13

Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

63 enrolled 13 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00038090 2018-10-31

Thalidomide-Dexamethasone for Multiple Myeloma

83 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

80 enrolled

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

70 enrolled

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02419118 2017-11-07

DARA

4 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00861250 2016-06-17

Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT

47 enrolled

Multiple Myeloma

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

Phase 2/3 Terminated

150 enrolled

Head & Neck

Mouth Neoplasms

NCT00002499 2013-09-20

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia